disease-free survival in impower010 trial: adjuvant atezolizumab in nsclc
Published 3 years ago • 373 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
4:50
impower010: adjuvant atezolizumab improves dfs in resected stage ii-iiia nsclc
-
1:41
adjuvant atezolizumab in nsclc
-
4:48
keynote-091 and impower010: adjuvant chemotherapy for nsclc
-
1:58
impower 010: adjuvant atezolizumab in nsclc - onctalk lung 2023
-
3:17
impower010: os results of atezolizumab vs best supportive care in resected nsclc
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
8:20
impower010: atezolizumab versus best supportive care after adjuvant chemotherapy in resected nsclc
-
21:02
what did we learn from impower010 in resectable nsclc? - medpage today
-
7:36
dr bhuvan | impower010 adjuvant atezolizumab after adjuvant chemotherapy in resected stage ib iiia
-
6:09
impower010: a phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy ...
-
5:41
javelin lung100, primus, nintnivo, impower010: investigating io in nsclc
-
15:00
podcast 299: lung cancer and atezolizumab — results from the impower010 trial
-
2:19
checkmate 274: biomarkers linked to disease-free survival with adjuvant nivolumab
-
1:39
lcmc3: adjuvant and neoadjuvant atezolizumab in early-stage ncslc
-
4:44
is disease-free survival a meaningful endpoint in nsclc? - medpage today
-
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
5:10
disease-free survival: endpoint for adjuvant therapy for cancer?